Pasithea Therapeutics Corp. (KTTAW)

US — Healthcare Sector
Peers: KTTA  BFRIW  LIXTW  DRMAW  JSPRW 

Automate Your Wheel Strategy on KTTAW

With Tiblio's Option Bot, you can configure your own wheel strategy including KTTAW - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol KTTAW
  • Rev/Share 0.0
  • Book/Share 5869.5468
  • PB 0.0001
  • Debt/Equity 0.0
  • CurrentRatio 3.8403
  • ROIC -0.0011

 

  • MktCap 5765795.0
  • FreeCF/Share -1386.2833
  • PFCF -0.0019
  • PE -0.1259
  • Debt/Assets 0.0
  • DivYield 0
  • ROE -0.0042

 

  • Rating B-
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 5
  • P/B Score 5
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

About Pasithea Therapeutics Corp. (KTTAW)

  • IPO Date 2021-09-15
  • Website http://pasitheaclinics.com
  • Industry Biotechnology
  • CEO Dr. Tiago Reis Marques M.D., Ph.D.
  • Employees 4
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. The company also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. Pasithea Therapeutics Corp. was incorporated in 2020 and is based in Miami Beach, Florida.